It was heartwarming looking at my son Max’s picture at the Patan Hospital: Pat Garcia-Gonzalez
Read the interview with the Nepal Live Today – October 21, 2024.
Join us November 6th for the International CML Foundation Forum at AORTIC
The African Organization for Research and Training in Cancer conference (AORTIC), happening November 5–8, 2019 brings together leading cancer specialists from around the world.
During the conference, attendees are invited to join The Max Foundation and the International and Chronic Myeloid Leukemia Foundation (iCMLf) for an interactive session for African Physicians Treating CML.
When:
Wednesday, November 6 from 5–8 PM at the Radisson Blu Hotel, adjacent to the AORTIC conference center in Maputo, Mozambique.
Discussion Topics:
In this session leading physicians and experts will discuss the following:
- Monitoring CML in a low-resource setting
- Responsible management in the era of 5 TIKs
- Meet the expert: Small group discussions
Get to know the speakers:
- Oliver Henke (Tanzania/Germany) |Professional Bio
- Amma Benneh Akwasi Kuma (Ghana) | Professional Bio
- Professor Tim Hughes (Australia) | Professional Bio
- Anthony Oyekunle (Nigeria/Botswana) | Professional Bio
- Durosinmi (Nigeria) | Professional Bio
- Gebremedhin (Ethiopie) | Professional Bio
This is an opportunity to join in-person to learn from the experts and exchange valuable ideas and transformative practices. Light dinner refreshments will be served.
To reserve your place please email Arlene Harris-Buchan.
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 27 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
Related Articles
The Max Foundation (Max) Expands Collaboration with Novartis to Include Access to Innovative Treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH)
Max to immediately begin process to provide humanitarian access for Fabhalta® (iptacopan) in collaboration with its network of partner hematologists across 53 countries People living with the rare blood disease in low-middle income countries require frequent blood transfusions, experience debilitating symptoms of fatigue and without treatment may progress to more serious life-threatening diseases The Max….
The Max Foundation Announces Multi-Stakeholder Collaboration to Improve Outcomes for People Living with Advanced Breast Cancer in Low-Resource Countries
Humanitarian Partnership for Access to Cancer Treatment (PACT) to launch in 5 countries in 2023 providing access to treatment and support for HR+/HER2- advanced breast cancer The Max Foundation, the ABC Global Alliance, the American Society of Clinical Pathology, Cepheid and Novartis AG are joining and committing resources to a unique collaboration Breast cancer is….
